IL6 and postmenopausal osteoporosis: Both falcarindiol and tetrahydrocoptisine demonstrated direct interaction with pro-inflammatory cytokines IL6, IL1B, and TNF, key drivers of osteoclastogenesis and bone resorption in postmenopausal osteoporosis by activating inflammatory pathways linked to bone loss [36].